255 related articles for article (PubMed ID: 16762189)
1. [Expression and significance of gonadotropin-releasing hormone receptor in the endometrium of normal and endometrial cancer uterus].
Yue Y; Piao JX; Wang LN; Pu JW; Gao FD
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):326-8. PubMed ID: 16762189
[TBL] [Abstract][Full Text] [Related]
2. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium.
Imai A; Ohno T; Iida K; Fuseya T; Furui T; Tamaya T
Gynecol Oncol; 1994 Oct; 55(1):144-8. PubMed ID: 7959256
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin releasing hormone receptor gene and protein expression and immunohistochemical localization in bovine uterus and oviducts.
Singh R; Graves ML; Roskelley CD; Giritharan G; Rajamahendran R
Domest Anim Endocrinol; 2008 Apr; 34(3):319-26. PubMed ID: 18035513
[TBL] [Abstract][Full Text] [Related]
4. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
[TBL] [Abstract][Full Text] [Related]
5. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
[TBL] [Abstract][Full Text] [Related]
6. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
[TBL] [Abstract][Full Text] [Related]
7. GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.
Nagai N; Oshita T; Mukai K; Shiroyama Y; Shigemasa K; Ohama K
Int J Mol Med; 2002 Nov; 10(5):593-7. PubMed ID: 12373298
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
10. Expression of maspin in endometrioid adenocarcinoma of endometrium.
Li HW; Leung SW; Chan CS; Yu MM; Wong YF
Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
[TBL] [Abstract][Full Text] [Related]
11. [Expression of estrogen receptor-related receptor isoforms in endometrial carcinoma tissues and its clinical significance].
Gao M; Wei LH; Sun PM; Zhao D; Wang JL; Wang ZQ; Zhao C
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):756-60. PubMed ID: 16324250
[TBL] [Abstract][Full Text] [Related]
12. Expression of human Biot2 and its potential function on carcinogenesis in endometrial cancer.
Yangmei S; Xiang H; Hongxin D; Hanshuo Y; Feng P; Yuping X; Yuquan W; Xia Z
Acta Obstet Gynecol Scand; 2007; 86(12):1503-9. PubMed ID: 18027117
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers.
Furui T; Imai A; Tamaya T
Oncol Rep; 2002; 9(2):349-52. PubMed ID: 11836606
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
15. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
16. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
17. Epithelial human chorionic gonadotropin is expressed and produced in human secretory endometrium during the normal menstrual cycle.
Zimmermann G; Ackermann W; Alexander H
Biol Reprod; 2009 May; 80(5):1053-65. PubMed ID: 19164178
[TBL] [Abstract][Full Text] [Related]
18. [Expression and activation of insulin receptor substrate-1 in endometrial carcinoma].
Hua SF; Xue FX; Zhang LZ; Wang YM; Zhao J
Zhonghua Fu Chan Ke Za Zhi; 2008 Jun; 43(6):437-41. PubMed ID: 19035139
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone (GnRH) and GnRH receptor in bladder cancer epithelia and GnRH effect on bladder cancer cell proliferation.
Bahk JY; Kim MO; Park MS; Lee HY; Lee JH; Chung BC; Min SK
Urol Int; 2008; 80(4):431-8. PubMed ID: 18587256
[TBL] [Abstract][Full Text] [Related]
20. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines.
Tieva A; Bergh A; Damber JE
Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
